Floatz logo

Therapeutic Asset Ratings

3,272 results matching 1 filter

91,564 assets7,904 sponsors3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Ipatasertib
Metastatic Malignant Neoplasm
National Cancer Institute (NCI)P2CCC (51)
Kras Tcr-Transduced Pbl
Cholangiocarcinoma
National Cancer Institute (NCI)P2CCC (51)
Larotrectinib
Colorectal Carcinoma
National Cancer Institute (NCI)P2CCC (51)
Levofolinic Acid
Acute Leukemia Of Ambiguous Lineage
National Cancer Institute (NCI)P2CCC (51)
mk-2206
Her2-Receptor Negative Breast Cancer
National Cancer Institute (NCI)P2CCC (51)
muc1 peptide-poly-iclc vaccine
Colorectal Carcinoma
National Cancer Institute (NCI)P2CCC (51)
Muc-1 Peptide Vaccine
Colorectal Carcinoma
National Cancer Institute (NCI)P2CCC (51)
Navitoclax
T-Cell Acute Lymphoblastic Leukemia
National Cancer Institute (NCI)P2CCC (51)
Nilotinib
Metastatic Malignant Neoplasm
National Cancer Institute (NCI)P2CCC (51)
Nogapendekin Alfa
Colorectal Carcinoma
National Cancer Institute (NCI)P2CCC (51)
Nogapendekin Alfa Inbakicept
Castration-Resistant Prostate Carcinoma
National Cancer Institute (NCI)P2CCC (51)
Nogapendekin Alfa Inbakicept
Prostate Cancer
National Cancer Institute (NCI)P2CCC (51)
Nogitecan
Myelofibrosis
National Cancer Institute (NCI)P2CCC (51)
Obeticholic Acid
Colorectal Carcinoma
National Cancer Institute (NCI)P2CCC (51)
Olaparib
Cholangiocarcinoma
National Cancer Institute (NCI)P2CCC (51)
Osimertinib
Colorectal Carcinoma
National Cancer Institute (NCI)P2CCC (51)
Osimertinib
Glioma
National Cancer Institute (NCI)P2CCC (51)
Pan-Fgfr Tyrosine Kinase Inhibitor Jnj-42756493
Colorectal Carcinoma
National Cancer Institute (NCI)P2CCC (51)
Pan-Fgfr Tyrosine Kinase Inhibitor Jnj-42756493
Glioma
National Cancer Institute (NCI)P2CCC (51)
Panitumumab
Primary Peritoneal Carcinoma
National Cancer Institute (NCI)P2CCC (51)
pds01adc
Cholangiocarcinoma
National Cancer Institute (NCI)P2CCC (51)
pds01adc
Colorectal Neoplasm
National Cancer Institute (NCI)P2CCC (51)
pds01adc
Intrahepatic Cholangiocarcinoma
National Cancer Institute (NCI)P2CCC (51)
Pertuzumab
Colorectal Carcinoma
National Cancer Institute (NCI)P2CCC (51)
Pertuzumab
Glioma
National Cancer Institute (NCI)P2CCC (51)
Showing 2301 to 2325 of 3,272 assets
PreviousPage 93 of 131Next